Effectiveness Research in Inflammatory Bowel Disease: A Necessity and a Methodological Challenge
Author:
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
http://academic.oup.com/ecco-jcc/article-pdf/10/9/1096/13746680/jjw068.pdf
Reference54 articles.
1. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
2. Watson RR Preedy VR . Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease . San Diego, CA: Academic Press, 2013.
3. Thaul S. How FDA Approves Drugs and Regulates Their Safety and Effectiveness . CreateSpace Independent Publishing Platform, createspace.com, 2012.
4. A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease
5. Lack of effectiveness of the platelet-activating factor antagonist SR27417A in patients with active ulcerative colitis: A randomized controlled trial
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term Outcome of Risankizumab in Crohn’s Disease: a Real-world GETAID Study;Clinical Gastroenterology and Hepatology;2024-05
2. Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn’s Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study;Inflammatory Bowel Diseases;2023-07-31
3. Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD‐study;Alimentary Pharmacology & Therapeutics;2023-06-15
4. Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study;Alimentary Pharmacology & Therapeutics;2022-12-19
5. Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study;European Journal of Gastroenterology & Hepatology;2022-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3